Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Plans To Step Up Enforcement Actions On Supplement Rx Contaminants

This article was originally published in The Tan Sheet

Executive Summary

FDA anticipates media coverage of its enforcement actions against firms marketing illegal supplement products will benefit responsible members of the industry, according to Center for Food Safety and Applied Nutrition Director Robert E. Brackett

You may also be interested in...



FDA Will Enforce NDI Notification Requirement Without Warning

FDA likely will not issue warnings before taking judicial actions against firms that fail to comply with the new dietary ingredient notification regulation once the agency publishes a long-awaited guidance

FDA Will Enforce NDI Notification Requirement Without Warning

FDA likely will not issue warnings before taking judicial actions against firms that fail to comply with the new dietary ingredient notification regulation once the agency publishes a long-awaited guidance

FDA Will Enforce NDI Notification Requirement Without Warning

FDA likely will not issue warnings before taking judicial actions against firms that fail to comply with the new dietary ingredient notification regulation once the agency publishes a long-awaited guidance

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100995

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel